Ashwin Jain

Ashwin Jain is a Principal Research Scientist at Pfizer, where they are currently engaged in developing solid dosage forms from Phase I to Phase III. They previously held positions at Wyeth Research, where they improved the bioavailability of poorly water-soluble drugs and developed various innovative dosage forms. Ashwin also contributed to formulation development at Emisphere Technologies and completed a summer internship at DuPont Pharmaceuticals. They are pursuing a Ph.D. in Pharmaceutical Sciences at Duquesne University while holding a B. Pharm degree from NDMVP's School of Pharmacy, Pune University.